Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial.
Dimopoulos MA, Richardson PG, Bahlis NJ, Grosicki S, Cavo M, Beksaç M, Legieć W, Liberati AM, Goldschmidt H, Belch A, Magen H, Larocca A, Laubach JP, Petrucci MT, Reece D, White D, Mateos MV, Špička I, Lazaroiu M, Berdeja J, Kaufman JL, Jou YM, Ganetsky A, Popa McKiver M, Lonial S, Weisel K; ELOQUENT-1 investigators. Dimopoulos MA, et al. Among authors: magen h. Lancet Haematol. 2022 Jun;9(6):e403-e414. doi: 10.1016/S2352-3026(22)00103-X. Epub 2022 May 9. Lancet Haematol. 2022. PMID: 35550060 Clinical Trial.
Amino acid sequence homology of monoclonal serum free light chain dimers and tissue deposited light chains in AL amyloidosis: a pilot study.
Goldis R, Kaplan B, Arad M, Dispenzieri A, Dasari S, Kukuy OL, Simon AJ, Dori A, Shavit-Stein E, Ziv T, Murray D, Kourelis T, Gertz MA, Dominissini D, Magen H, Muchtar E. Goldis R, et al. Among authors: magen h. Clin Chem Lab Med. 2023 Sep 26;62(3):464-471. doi: 10.1515/cclm-2023-0591. Print 2024 Feb 26. Clin Chem Lab Med. 2023. PMID: 37747270
Amyloid Typing in Cardiac Amyloidosis Using Western Blotting.
Kaplan B, Goldis R, Ziv T, Dori A, Magen H, Simon AJ, Volkov A, Maor E, Arad M. Kaplan B, et al. Among authors: magen h. Isr Med Assoc J. 2024 Mar;26(3):149-156. Isr Med Assoc J. 2024. PMID: 38493325 Free article.
Diagnostic Challenges and Solutions in Systemic Amyloidosis.
Goldis R, Kaplan B, Kukuy OL, Arad M, Magen H, Shavit-Stein E, Dori A, Livneh A. Goldis R, et al. Among authors: magen h. Int J Mol Sci. 2023 Feb 28;24(5):4655. doi: 10.3390/ijms24054655. Int J Mol Sci. 2023. PMID: 36902083 Free PMC article. Review.
Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study.
Shragai T, Magen H, Lavi N, Gatt M, Trestman S, Zektser M, Ganzel C, Jarchowsky O, Berger T, Tadmor T, Leiba M, Hertzog-Tzarfaty K, Horowitz N, Shapira M, Varssano D, Berger Y, Frenkel S, Krauthammer M, Avivi I, Luttwak E, Cohen YC; Israeli myeloma study group. Shragai T, et al. Among authors: magen h. Br J Haematol. 2023 Jan;200(1):45-53. doi: 10.1111/bjh.18479. Epub 2022 Oct 7. Br J Haematol. 2023. PMID: 36205375 Free PMC article.
Clinical features, therapy patterns, outcomes and prognostic factors of solitary plasmacytomas: a report of the Israeli Myeloma Study Group.
Ganzel C, Trestman S, Levi S, Gatt ME, Lavi N, Vaxman I, Rouvio O, Magen H, Lebel E, Horowitz NA, Leiba M, Tadmor T, Herzog Tzarfati K, Surio C, Yeganeh S, Dally N, Avivi I, Cohen YC. Ganzel C, et al. Among authors: magen h. Leuk Lymphoma. 2022 Dec;63(14):3448-3455. doi: 10.1080/10428194.2022.2118535. Epub 2022 Sep 8. Leuk Lymphoma. 2022. PMID: 36075048
84 results